Hematopoietic stem cells for treatment of rheumatoid arthritis

The aim of this study is to assess the safety and feasibility  of autologous peripheral hematopoietic stem cell transplantation in patients with rheumatoid arthritis, following patient conditioning with high-dose cyclophosphamide and anti-thymocyte globulin.